- •Introduction to Genetics for… series
- •Preface
- •What the experts say
- •Acknowledgements
- •Contents
- •1. Corneal disease
- •2. Lens
- •3. Glaucoma
- •4. Inherited retinal disease
- •5. Vitreoretinal disorders
- •6. Optic nerve
- •7. Defects of pigmentation
- •8. Metabolic disorders
- •9. Conditions associated with increased risk of malignancy
- •10. Defects of ocular/adnexal development
- •11. Glossary
- •12. Abbreviations
- •13. Index
13
13. Index
ABCA4 (ATP-binding cassette, subfamily A, member 4) |
88–9, 99–101, 110, 134 |
||||||||||
ABCC6 (ATP-binding cassette, subfamily C, member 6) |
89, 94 |
||||||||||
N-acetylgalactosamine-4-sulfatase (ARSB) 236 |
|
|
|||||||||
achalasia–addisonianism–alacrima (AAAS) syndrome |
268–9 |
||||||||||
achromatopsia |
82–3 |
|
|
|
|
|
|
|
|
||
aculeiform cataract |
32–3 |
|
|
|
|
|
|
|
|||
adaptin beta-3a (AP3B1) |
|
209–10 |
|
|
|
|
|
||||
adenomatous polyposis of colon |
244–6 |
|
|
|
|||||||
adnexal developmental defects |
267–77 |
|
|
|
|||||||
age-related macular degeneration (ARMD) |
88–9 |
|
|
||||||||
AIPL1 (arylhydrocarbon-interacting receptor protein-like 1) |
115, 118 |
||||||||||
alacrima |
268–9 |
|
|
|
|
|
|
|
|
|
|
albinism (OCA) |
202–6, 211–2 |
|
|
|
|
|
|
||||
Allgrove syndrome |
268–9 |
|
|
|
|
|
|
|
|||
alpha subunit of rod transducin (GNAT1) |
142 |
|
|
||||||||
Alström syndrome |
147–8 |
|
|
|
|
|
|
|
|||
amyloidosis |
|
|
|
|
|
|
|
|
|
|
|
Finnish-type/Meretoja-type 20–2 |
|
|
|
|
|||||||
lattice corneal dystrophy, type I |
18–9 |
|
|
||||||||
primary subepithelial |
7 |
|
|
|
|
|
|
||||
amyloidosis V |
20–2 |
|
|
|
|
|
|
|
|
||
Anderson–Fabry disease |
215–6 |
|
|
|
|
|
|||||
aniridia |
65–7 |
|
|
|
|
|
|
|
|
|
|
anophthalmos |
274–5 |
|
|
|
|
|
|
|
|
||
anterior polar cataract 34 |
|
|
|
|
|
|
|
||||
anterior segment ocular (mesenchymal) dysgenesis (ASOD) |
68–9 |
||||||||||
AP3B1 (adaptin beta-3a) |
|
209 |
|
|
|
|
|
|
|||
APC (adenomatous polyposis of colon) |
244–6 |
|
|
||||||||
aquaporin O (AQPO) |
41 |
|
|
|
|
|
|
|
|
||
arachnodactyly |
53 |
|
|
|
|
|
|
|
|
|
|
ARMD (age-related macular degeneration) |
88 |
|
|
||||||||
arrestin (SAG S-antigen) |
134 |
|
|
|
|
|
|
||||
ARSB (N-acetylgalactosamine-4-sulfatase) |
236 |
|
|
||||||||
arthro-ophthalmopathy, progressive |
180–4 |
|
|
||||||||
arylhydrocarbon-interacting receptor protein-like 1 (AIPL1) |
118 |
||||||||||
ATP-binding cassette, subfamily A, member 4 (ABCA4) |
88–9, 99–100, 134 |
||||||||||
ATP-binding cassette, subfamily C, member 6 (ABCC6) |
89, 94 |
||||||||||
Avellino-type corneal dystrophy |
14–7 |
|
|
|
|
||||||
Axenfeld anomalies |
68, 72, 77 |
|
|
|
|
|
|
||||
Bardet–Biedl syndrome |
149–52 |
|
|
|
|
|
|||||
basal cell nevus syndrome |
247–50 |
|
|
|
|
|
|||||
Batten disease |
231–3 |
|
|
|
|
|
|
|
|
||
BBS2, BBS4 |
151–2 |
|
|
|
|
|
|
|
|
||
Best macular dystrophy |
104–6 |
|
|
|
|
|
|
||||
beta-Ig-H3/transforming growth factor (BIGH/TGFB1) |
10–9 |
||||||||||
bicoid-related homeobox-containing gene |
78 |
|
|
||||||||
BIGH3-related dystrophies 4 10–9 |
|
|
|
|
|
||||||
342 |
Genetics for Ophthalmologists |
Blaschko’s lines |
173 |
|
|
|
|
|
|
|
|||
blepharophimosis, ptosis and epicanthus inversus |
270–1 |
||||||||||
Bloch–Sulzberger syndrome |
172–4 |
|
|
|
|
||||||
blue cone monochromatic color blindness |
84–5 |
|
|
||||||||
Bowman’s layer dystrophy |
|
|
|
|
|
|
|
||||
type I |
10–1 |
|
|
|
|
|
|
|
|
||
type II |
12–3 |
|
|
|
|
|
|
|
|
||
buphthalmos |
58–60 |
|
|
|
|
|
|
|
|||
cadherin-like gene CDH23 |
166 |
|
|
|
|
|
|||||
calcium channel alpha-1 subunit (CACNA1F) |
142 |
|
|||||||||
carbohydrate sulfotransferase-6 (CHST6) |
24 |
|
|
|
|||||||
cataract |
28–44 |
|
|
|
|
|
|
|
|
|
|
aculeiform |
32–3 |
|
|
|
|
|
|
|
|||
autosomal dominant (ADCC) |
29 |
|
|
|
|
||||||
autosomal recessive (ARCC) 30 |
|
|
|
|
|||||||
cerulean (blue-dot) |
36–7 |
|
|
|
|
|
|||||
congenital zonular with sutural opacities |
38 |
|
|||||||||
Coppock-like |
39–40 |
|
|
|
|
|
|
||||
embryonic nuclear |
39–40 |
|
|
|
|
|
|||||
hyperferritinemia–cataract syndrome |
45 |
|
|
|
|||||||
Lowe (oculocerebrorenal) syndrome |
46–8 |
|
|
||||||||
myotonic dystrophy |
49–51 |
|
|
|
|
|
|||||
polymorphic and lamellar 41 |
|
|
|
|
|
||||||
posterior polar |
42 |
|
|
|
|
|
|
|
|||
syndromic |
45–51 |
|
|
|
|
|
|
|
|||
X-linked |
|
|
|
|
|
|
|
|
|
||
|
with Hutchinsonian teeth |
35 |
|
|
|
|
|||||
|
Lowe syndrome |
46–8 |
|
|
|
|
|
||||
zonular pulverulent |
43–4 |
|
|
|
|
|
|||||
cataract–dental syndrome |
|
35 |
|
|
|
|
|
||||
CBBM (blue cone monochromatic color blindness) |
84–5 |
||||||||||
CEH10 homeodomain-containing homolog (CHX10) |
276 |
||||||||||
cellular retinaldehyde-binding protein 1 (CRBP1) |
120 |
||||||||||
central areolar choroidal dystrophy (CACD) |
127–9 |
|
|||||||||
cerebellar vermis agenesis |
|
158 |
|
|
|
|
|
||||
cerebelloparenchymal disorder IV (CPDIV) |
158 |
|
|
||||||||
ceroid lipofuscinosis type-3 |
231–3 |
|
|
|
|
||||||
CFEOM (congenital fibrosis of extraocular muscles) |
272–3 |
||||||||||
Chediak–Higashi syndrome |
207–8 |
|
|
|
|
||||||
choroid, and retina, gyrate atrophy |
226–7 |
|
|
|
|||||||
choroidal dystrophy, central areolar |
127–9 |
|
|
|
|||||||
choroidal sclerosis (choroideremia) |
107–9 |
|
|
|
|||||||
choroiditis, Doyne honeycomb retinal dystrophy |
90–1 |
||||||||||
CHRPEs, retinal pigment epithelium |
244 |
|
|
|
|
||||||
CHX10 (CEH10 homeodomain-containing homolog) |
276 |
||||||||||
CLN3 (ceroid lipofuscinosis type-3) |
231–3 |
|
|
|
|||||||
CNGA1 |
134 |
|
|
|
|
|
|
|
|
|
|
Index |
343 |
Cockayne syndrome |
153–5 |
|
|
|
|
|||||
COD(3) 86–7 |
|
|
|
|
|
|
|
|
||
Cohen syndrome |
156–7 |
|
|
|
|
|
||||
collagens |
|
|
|
|
|
|
|
|
|
|
type II,alpha1 (COL2A1) |
183 |
|
|
|||||||
type VIII,alpha2 (COL8A2) |
26 |
|
||||||||
type XI,alpha1 (COL11A1) |
183 |
|
||||||||
type XVIII,alpha1 (COL18A1) |
175 |
|
||||||||
coloboma with renal disease (ONCR) |
194–5 |
|||||||||
color blindness, blue cone monochromatic |
84–5 |
|||||||||
cone dystrophies |
82–7 |
|
|
|
|
|
||||
cone–rod dystrophy |
110–1 |
|
|
|
|
|||||
cone–rod homeobox (CRX) |
119 |
|
|
|
||||||
connexins (CX) 43–4 |
|
|
|
|
|
|
||||
Coppock-like cataract |
|
39–40 |
|
|
|
|||||
CORD1–9 |
110 |
|
|
|
|
|
|
|
|
|
CORD3 (Stargardt disease) |
98–101 |
|
||||||||
cornea plana |
5–6 |
|
|
|
|
|
|
|
||
corneal amyloidosis, primary subepithelial |
7 |
|||||||||
corneal dystrophies |
3–26 |
|
|
|
|
|
||||
CDBI |
10–1 |
|
|
|
|
|
|
|
|
|
CDBII |
12–3 |
|
|
|
|
|
|
|
||
chromosomal localization 4 |
|
|
||||||||
Fuchs’ endothelial |
25–6 |
|
|
|
||||||
Granular |
14–7 |
|
|
|
|
|
|
|||
Groenouw type I |
|
14–7 |
|
|
|
|
||||
Groenouw type II |
23–4 |
|
|
|
||||||
honeycomb |
12–3 |
|
|
|
|
|
||||
inheritance pattern 4 |
|
|
|
|
|
|||||
lattice |
18–22 |
|
|
|
|
|
|
|
||
corneal shape abnormalities |
|
2–6 |
|
|
||||||
CRD (cone-rod dystrophy) |
110–1 |
|
|
|||||||
CREB-binding protein (CREBPP) |
79–80 |
|
||||||||
Criswick–Schepens syndrome |
170–1 |
|
||||||||
crumbs homolog 1 (CRB1) |
134, 135 |
|
||||||||
CRX 126 |
|
|
|
|
|
|
|
|
|
|
crystallins (CRY) |
29, 30 |
|
|
|
|
|
||||
alphaA (CRYAA) 276 |
|
|
|
|
|
|||||
alphaB (CRYAB) 42 |
|
|
|
|
|
|||||
betaA1 (CRYBA1) 36 |
|
|
|
|
||||||
betaB2 (CRYBB2) |
36, 39, 276 |
|
||||||||
gamma (CRYG) 40 |
|
|
|
|
|
|||||
gammaD (CRYGD) 32 |
|
|
|
|
||||||
CSNB1–3 |
141 |
|
|
|
|
|
|
|
|
|
cyclic nucleotide-gated cation channel |
|
|||||||||
alpha subunit (CNGA3) |
82 |
|
|
|
||||||
beta subunit (CNGB3) |
|
82 |
|
|
|
|||||
cystathionine beta-synthase (CBS) |
228–30 |
|||||||||
344 |
Genetics for Ophthalmologists |
cystinosin (CTNS) 237–8 cytochrome P450B1 (CYP1B1) 2, 59
de Morsier syndrome 196–8 deafness 199–200
diabetes mellitus, diabetes insipidus, optic atrophy and deafness (DIDMOAD) 199–200
digenic retinitis pigmentosa 137 dominant optic atrophy, type-1 188–9
Doyne honeycomb retinal dystrophy (choroiditis) 90–1
Drosophila homologs
crumbs 1 (CRB1) |
134, 135 |
patched (PTCH) |
250 |
drusen, radial 90–1
dystrophia myotonica protein kinase (DMPK) 49–51
ectopia lentis 52–6
EGF-containing fibrillin-like extracellular matrix protein-1 (EFEMP1) 89, 91
elongation of VLC fatty acids-like gene 4 (ELOVL4) |
89, 103 |
||||
embryonic nuclear cataract |
39–40 |
|
|||
endothelial |
25–6 |
|
|
|
|
enhanced S–cone syndrome |
112–3 |
|
|||
epicanthus inversus 270–1 |
|
|
|||
ERCC6, ERCC8 |
154 |
|
|
|
|
exudative vitreoretinopathy |
|
|
|||
EVR1 |
170–1 |
|
|
|
|
X-linked (EVR2) |
177–9 |
|
|||
Fabry disease |
215–6 |
|
|
|
|
familial adenomatous polyposis (FAP) 244–6 |
|
||||
familial iridogoniodysplasia |
72–3 |
|
|||
FECD (Fuchs’ endothelial corneal dystrophy) 25–6 |
|
||||
ferritin light chain (FLC) |
45 |
|
|
||
fibrillin 1 (FBN1) 55 |
|
|
|
||
fibrillin-like extracellular matrix protein-1 (EFEMP1) |
89, 91 |
||||
fibrosis of extraocular muscles (FEOM1, FEOM2) 272–3
fifth phakomatosis |
247–50 |
|
||
Finnish-type amyloidosis |
20–2 |
|
||
forkhead box C1 (FOXC1) |
72 |
|
||
forkhead box E3 (FOXE3) |
68 |
|
||
forkhead transcription factor (FOXL2) |
271 |
|||
Franceschetti sign |
114 |
|
|
|
Fuchs’ endothelial corneal dystrophy |
25–6 |
|||
fundus albipunctatus |
144–5 |
|
||
fundus flavimaculatus |
98–101, 102–3 |
|||
galactose-1-phosphate uridyltransferase (GALT) deficiency 219–21
galactosemia |
219–21 |
cataract |
47 |
Index |
345 |
galactokinase deficiency |
217–8 |
|
|
|
||||
galactosidase alpha (GLA) |
216 |
|
|
|
|
|||
galactosidase beta (GLB1) |
236 |
|
|
|
|
|||
GALNS (galactosamine-6-sulfate sulfatase) |
236 |
|||||||
Gardner syndrome 244–6 |
|
|
|
|
|
|
||
gelatinous drop-like corneal dystrophy |
7 |
|
|
|||||
gelsolin 21 |
|
|
|
|
|
|
|
|
geographic granular dystrophy |
10–1 |
|
|
|
||||
glaucoma |
57–80 |
|
|
|
|
|
|
|
primary 58–64 |
|
|
|
|
|
|
||
congenital glaucoma |
58–60 |
|
|
|||||
juvenile open angle |
61–2 |
|
|
|
||||
open angle glaucoma |
63–4 |
|
|
|||||
secondary |
65–80 |
|
|
|
|
|
|
|
glaucoma-related pigment dispersion syndrome |
70–1 |
|||||||
GM2 gangliosidosis |
|
|
|
|
|
|
||
type I |
222–5 |
|
|
|
|
|
|
|
type II |
222–5 |
|
|
|
|
|
|
|
GNAT1 (alpha subunit of rod transducin) 142 |
|
|||||||
Goldmann–Favre syndrome |
112 |
|
|
|
|
|||
Gorlin–Golz syndrome 247–50 |
|
|
|
|
||||
granular corneal dystrophy |
14–7 |
|
|
|
||||
granular dystrophy, geographic |
10–1 |
|
|
|
||||
green cone pigment, including deuteranopia |
84 |
|||||||
Groenouw corneal dystrophy |
|
|
|
|
|
|||
type I |
14–7 |
|
|
|
|
|
|
|
type II |
23–4 |
|
|
|
|
|
|
|
Grönblad–Strandberg syndrome |
92–5 |
|
|
|||||
GTPases, Rab escort proteins |
108 |
|
|
|
||||
guanylate cyclase |
|
|
|
|
|
|
|
|
2D (GUCY2D) 116 |
|
|
|
|
|
|
||
activator 1A (GUCAA1A) |
7 |
|
|
|
|
|||
gyrate atrophy of choroid and retina 226–7 |
|
|
||||||
harmonin |
165 |
|
|
|
|
|
|
|
heparan sulfate proteoglycans |
76 |
|
|
|
||||
Hermansky–Pudlak syndrome |
209–10 |
|
|
|||||
hexosaminidase A/B deficiency, HEXA, HEXB |
222–5 |
|||||||
von Hippel–Lindau syndrome |
264–5 |
|
|
|
||||
homeobox gene expressed in ES cells (HESX1) |
197 |
|||||||
homocystinuria |
228–30 |
|
|
|
|
|
|
|
honeycomb corneal dystrophy |
12–3 |
|
|
|
||||
honeycomb degeneration of retina |
90–1 |
|
|
|||||
HPS 209–10 |
|
|
|
|
|
|
|
|
Hunter syndrome |
234–6 |
|
|
|
|
|
|
|
Hurler syndrome |
234–6 |
|
|
|
|
|
|
|
Hutchinsonian teeth, X-linked cataract |
35 |
|
|
|||||
hyperferritinemia–cataract syndrome |
45 |
|
|
|||||
346 |
Genetics for Ophthalmologists |
IDS (iduronate sulfatase) |
236 |
|
|
|||
IDUA (alpha-L-iduronidase) |
236 |
|
||||
incontinentia pigmenti type II (IP2) |
172–4 |
|||||
infantile nephropathic cystinosis |
237–8 |
|||||
inherited retinal disease |
81–167 |
|
||||
iridogoniodysgenesis |
72–3, 77–8 |
|
||||
anomaly (IGDA) |
72–3 |
|
|
|
||
with somatic anomalies |
77–8 |
|||||
type I |
72–3 |
|
|
|
|
|
type II |
77–8 |
|
|
|
|
|
iris hypoplasia 77–8 |
|
|
|
|
|
|
isolated ectopia lentis |
52–6 |
|
|
|
||
isolated microphthalmos |
274–5 |
|
||||
Joubert–Bolthauser syndrome |
158 |
|||||
juvenile familial corneal dystrophy |
8–9 |
|||||
juvenile neuronal ceroid lipofuscinosis, type-3 231–3 juvenile optic atrophy 188–9
juvenile-onset primary open angle glaucoma (JOAG) 61–2
Kearns–Sayre syndrome 160
keratan sulfate, carbohydrate sulfotransferase-6 (CHST6) 24
keratan sulfate proteoglycans (KSPGs) |
6 |
|
|||||
keratocan (KERA 5) |
276 |
|
|
|
|||
Kjer-type optic atrophy 188–9 |
|
|
|
||||
Knobloch syndrome |
175–6 |
|
|
|
|||
Krukenberg spindles |
70 |
|
|
|
|||
lattice corneal dystrophy |
|
|
|
||||
|
type I |
18–9 |
|
|
|
|
|
|
type II |
20–2 |
|
|
|
|
|
Leber congenital amaurosis (LCA) |
114–9 |
|
|||||
Leber hereditary optic atrophy/neuropathy 190–3 |
|
||||||
lens, anatomy |
29 |
|
|
|
|
||
lens disorders 27–56 |
|
|
|
||||
lens subluxation |
53–6 |
|
|
|
|||
|
homocystinuria |
228–30 |
|
|
|
||
Lester sign |
75 |
|
|
|
|
|
|
LIM homeobox transcription factor 1beta (LMX1B) |
74 |
||||||
LIM2 |
30 |
|
|
|
|
|
|
Lowe (oculocerebrorenal) syndrome |
46–8 |
|
|||||
LRAT |
134 |
|
|
|
|
|
|
lysosomal trafficking regulator (LYST) |
207 |
|
|||||
McKusick–Kaufman syndrome 152 |
|
|
|||||
macular corneal dystrophy 23–4 |
|
|
|
||||
macular dystrophies |
88–106 |
|
|
|
|||
macular pattern dystrophy, deafness and diabetes |
161 |
||||||
Index |
347 |
MAF 2, 276 |
|
|
|
major intrinsic protein of lens fiber membrane (MIP) 41 |
|||
Malattia Leventinese (MLVT) |
90–1 |
|
|
malignancy (increased risk) |
241–65 |
||
Knudson’s two-hit hypothesis |
242 |
||
Marfan syndrome |
52–6 |
|
|
Maroteux–Lamy syndrome 234–6 |
|
||
MASS phenotype |
56 |
|
|
MCDC (macular corneal dystrophy |
23–4 |
||
Meesmann corneal dystrophy |
8–9 |
|
|
membrane component, chr-1, surface marker-1 (M1S1) 7
Meretoja-type amyloidosis |
20–2 |
|
||||
merlin |
255 |
|
|
|
|
|
MERTK |
134 |
|
|
|
|
|
mesenchymal dysgenesis, anterior segment 68–9 |
||||||
metabolic disorders |
213–40 |
|
||||
MFS1 (Marfan syndrome) |
|
52–6 |
|
|||
microphthalmos, isolated |
274–5 |
|
||||
mitochondrial disease and retinopathy |
159–62 |
|||||
mitochondrial genes, LHON |
190–3 |
|
||||
MKKS (McKusick–Kaufman syndrome) |
152 |
|||||
Morquio syndrome |
234–6 |
|
|
|||
de Morsier syndrome |
196–8 |
|
||||
mucopolysaccharidoses |
234–6 |
|
||||
multidrug resistance protein 6 (MRP6) |
94 |
|||||
myocilin (MYOC) 62–4 |
|
|
|
|||
myosin VIIa 165 |
|
|
|
|
||
myotonic dystrophy |
49–51 |
|
||||
nail dystrophy |
174 |
|
|
|
|
|
nail–patella syndrome |
74–6 |
|
||||
Nance–Horan sydrome (NHS) 35 |
|
|||||
nanophthalmos |
274–5 |
|
|
|
||
NARP (neuropathy, ataxia and retinitis pigmentosa) 162
NDP (Norrie disease) 177–9 |
|
|
||
nephropathic cystinosis 237–8 |
|
|
||
Nettleship–Falls type ocular albinism |
211–2 |
|
||
neurofibromatosis |
|
|
||
type I |
251–3 |
|
|
|
type II |
254–6 |
|
|
|
neurofibromin (NF1) 253 |
|
|
||
neuronal ceroid lipofuscinosis, juvenile type-3 |
231–3 |
|||
neuropathy, ataxia and retinitis pigmentosa 162 |
||||
nevoid basal cell carcinoma syndrome (NBCCS) |
247–50 |
|||
NFκB essential modulator (NEMO) |
174 |
|
||
night blindness |
141–4 |
|
|
|
Norrie disease |
177–9 |
|
|
|
NRL 126 |
|
|
|
|
348 |
Genetics for Ophthalmologists |
nuclear receptor subfamily 2, group E, member 3 (NR2E3) 112 nyctalopin (NYX) 142
OA1, X-linked albinism |
211–2 |
|
||
OAT (ornithine aminotransferase) 226–7 |
||||
occipital encephalocoele |
175–6 |
|
||
OCRL (oculocerebrorenal syndrome) |
46–8 |
|||
ocular albinism, type-1 |
211–2 |
|
||
ocular/adnexal developmental defects |
267–7 |
|||
oculocerebrorenal syndrome |
46–8 |
|
||
oculocutaneous albinism |
202–6 |
|
||
Oguchi disease |
145–6 |
|
|
|
onychoosteodysplasia 74–6 |
|
|
||
OPA1 (optic atrophy type 1) |
188–9 |
|
||
open-angle glaucoma type 1a (GLCIA) |
61–2 |
|||
optic atrophy |
187–200 |
|
|
|
DIDMOAD 199–200 |
|
|
||
optic nerve coloboma with renal disease (ONCR) 194–5 ornithine aminotransferase (OAT) deficiency 226–7
paired box gene 2 (PAX2) |
192 |
paired box gene 6 (PAX6) |
66 |
paired-like homeodomain transcription factors (PITX2) 78
(PITX3) 68
patched homolog (PTCH) 250 patellar aplasia 74–6
PCDH15 166
PDE6A 134
PDE6B 134, 142 peripherin/RDS-related RP 87, 127–9 Peters’ anomaly 68, 77
phytanoyl-CoA hydroxylase (PHYH) 240
pigment dispersion syndrome (pigmentary glaucoma) 70–1
pigmentation defects |
201–12 |
|
|
|
red and green cone pigment |
84 |
|
||
pink-eye (P) gene 205 |
|
|
||
polymorphic and lamellar cataract |
41 |
|
||
posterior polar cataract |
42 |
|
|
|
posterior polymorphous dystrophy (PPCD) |
25–6 |
|||
primary subepithelial corneal amyloidosis |
7 |
|||
progressive arthro-ophthalmopathy |
180–4 |
|||
progressive cone dystrophy 86–7, 127 |
|
|||
progressive rod–cone dystrophies |
122–40 |
|||
PROML1 |
134 |
|
|
|
PRPC8 |
126 |
|
|
|
pseudoxanthoma elasticum (PXE) |
92–5 |
|
||
ptosis and epicanthus inversus 270–1 |
|
|||
Index |
349 |
Rab escort protein 1 (REP-1) 108 radial drusen 90–1
Rathke pouch homeobox (RPX) |
197 |
||||
RB1 (retinoblastoma) 257–60 |
|
||||
RBP4 |
134 |
|
|
|
|
RDH5 (retinol dehydrogenase 5) |
143 |
||||
RDS/peripherin (RDS) 87, 89, 126, 129 |
|||||
von Recklinghausen disease |
251–3 |
||||
red cone pigment, including protanopia 84 |
|||||
Refsum disease |
239–40 |
|
|
||
Reis–Buckler’s corneal dystrophy |
10–1 |
||||
renal–coloboma syndrome |
194–5 |
||||
RetGC1 |
116 |
|
|
|
|
retina, and choroid, gyrate atrophy 226–7 |
|||||
retinal degeneration slow (RDS) |
87, 89, 126, 129 |
||||
retinal detachment |
175–6 |
|
|
||
retinal dystrophies |
81–167 |
|
|||
cone 82–7 |
|
|
|
||
macular |
88–106 |
|
|
||
miscellaneous |
107–21 |
|
|||
mitochondrial diseases |
159–62 |
||||
progressive rod–cone |
122–40 |
||||
stationary night blindness |
141–4 |
||||
syndromic |
147–67 |
|
|
||
retinal pigment epithelium, congenital hypertrophic lesions (CHRPEs) 244 retinal pigment epithelium-specific protein (RPE65) 117, 134 retinaldehyde-binding protein 1 (RBP1) 120
retinitis pigmentosa 122–40 |
|
||||
autosomal dominant |
125–6 |
||||
genes |
125–6 |
|
|
||
autosomal recessive |
132–6 |
||||
genes |
134 |
|
|
||
digenic |
137 |
|
|
|
|
peripherin/RDS |
127–9 |
|
|||
PPRPE type |
135–6 |
|
|
||
rhodopsin-related |
130–1 |
|
|||
stationary night blindness |
141–6 |
||||
type-12 (RP12) |
135–6 |
|
|||
X-linked |
138–40 |
|
|
||
genes |
139 |
|
|
||
retinitis punctata albescens |
120–1, 127 |
||||
retinoblastoma 257–60 |
|
|
|||
retinol dehydrogenase 5 (RDH5) |
143 |
||||
retinoschisis, X-linked |
185–6 |
|
|||
RGR 134 |
|
|
|
|
|
RHO (rhodopsin-related RP) 130–1, 142 |
|||||
RHOK (rhodopsin kinase) |
146 |
|
|||
Rieger anomalies |
68, 72 |
|
|
||
350 |
Genetics for Ophthalmologists |
Rieger syndrome |
72, 77–8 |
|
|
|
|
|
||||
RLBP1 |
134 |
|
|
|
|
|
|
|
|
|
rod, see also cone–rod |
|
|
|
|
|
|
|
|||
rod monochromatism |
82–3 |
|
|
|
|
|
||||
rod outer segment protein 1 (ROM1) |
137 |
|
|
|||||||
rod transducin, alpha subunit (GNAT1) |
142 |
|
|
|||||||
ROM/RDS 126, 137 |
|
|
|
|
|
|
|
|||
RP1 |
126 |
|
|
|
|
|
|
|
|
|
RP2 |
139 |
|
|
|
|
|
|
|
|
|
RPA (retinitis punctata albescens) 120–1 |
|
|
||||||||
RPE65 (retinal pigment epithelium-specific protein) |
117–8, 134 |
|||||||||
RPGR |
|
139 |
|
|
|
|
|
|
|
|
RPGRIP1 (RPGR-interacting protein) |
118 |
|
|
|||||||
RPX (Rathke pouch homeobox) |
197 |
|
|
|
|
|||||
RSI X-linked retinoschisis |
185–6 |
|
|
|
|
|||||
Rubinstein–Taybi syndrome |
79–80 |
|
|
|
|
|||||
SAG (S-antigen) |
134 |
|
|
|
|
|
|
|
||
Sandhoff disease (hexosaminidase B deficiency) |
222–5 |
|||||||||
SCH (schwannomin) |
255 |
|
|
|
|
|
|
|||
Scheie syndrome |
234–6 |
|
|
|
|
|
|
|||
septo–optic dysplasia |
196–8 |
|
|
|
|
|
||||
SFD (Sorsby pseudoinflammatory fundus dystrophy) |
96–7 |
|||||||||
SIX5 |
51 |
|
|
|
|
|
|
|
|
|
small leucine-rich proteoglycans (SLRPs) |
6 |
|
|
|||||||
Sorsby pseudoinflammatory fundus dystrophy |
96–7 |
|
||||||||
Stargardt disease |
98–103 |
|
|
|
|
|
||||
autosomal dominant |
102–3 |
|
|
|
|
|||||
autosomal recessive |
98–101 |
|
|
|
|
|||||
stationary night blindness |
141–6 |
|
|
|
|
|||||
Stickler syndrome |
180–4 |
|
|
|
|
|
|
|||
stromal |
21–4 |
|
|
|
|
|
|
|
|
|
subretinal neovascular membranes (SRNVMs) |
94 |
|
||||||||
Tay–Sachs disease (hexosaminidase A deficiency) 222–5 |
||||||||||
Thiel–Behnke corneal dystrophy |
12–3 |
|
|
|
||||||
tissue inhibitor of metalloproteinase 3 (TIMP3) |
89, 97 |
|||||||||
trabecular meshwork-induced glucocorticoid response (TIGR) 62 trinucleotide repeat (CTG) regions 50
triple-A syndrome 268–9
tuberous sclerosis complex (TSC1, TSC2) 261–3
TULP1 134
tumor predisposition 242–3 tumor suppressor genes
Knudson’s two-hit hypothesis 242 RB1 (retinoblastoma) 257–60
tyrosinase (TYR), OCA1 202–6 tyrosine-related protein (TYP1), OCA3 205–6
Index |
351 |
Usher syndrome 163–7
USH2A/usherin 134, 164
USH genes 164
VHL (von Hippel–Lindau) 264–5 vitelliform dystrophy (RDS-related) 127–8
vitelliform macular dystrophy (VMD2) 104–6 vitreoretinal disorders 169–86
VMD2 89,104–6
Vogt–Spielmeyer (Batten) disease 231–3
von Hippel–Lindau syndrome |
264–5 |
von Recklinghausen disease |
251–3 |
VSX1 2, 4, 25 |
|
WAGR (Wilms’ tumor, aniridia, genitourinary defects and retardation) 67
WFS1 (wolframin) |
199–200 |
|
|
Wolfram syndrome |
199–200 |
|
|
X-linked disorders |
|
|
|
anophthalmos |
274–5 |
|
|
cataract with Hutchinsonian teeth |
35 |
||
familial exudative vitreoretinopathy (EVR2) 177–9 |
|||
Hunter syndrome |
234–6 |
|
|
ocular albinism |
211–2 |
|
|
retinitis pigmentosa 138–40 |
|
||
retinoschisis |
185–6 |
|
|
zonular cataract, with sutural opacities |
38 |
||
zonular pulverulent cataract 43–4 |
|
||
352 |
Genetics for Ophthalmologists |
